Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5,525 INR | -0.86% | -3.35% | -0.48% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The group's high margin levels account for strong profits.
- The company is in a robust financial situation considering its net cash and margin position.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 30.11 times its estimated earnings per share for the ongoing year.
- The company's enterprise value to sales, at 4.41 times its current sales, is high.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The company is highly valued given the cash flows generated by its activity.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
Ratings chart - Surperformance
Sector: Agricultural Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-0.48% | 2.98B | - | ||
-.--% | 11.15B | - | B+ | |
-7.28% | 7.3B | A | ||
+7.47% | 6.87B | B- | ||
-3.91% | 5.91B | B+ | ||
-6.14% | 5.54B | B | ||
-10.44% | 5.6B | - | C- | |
+31.35% | 5.19B | B- | ||
-13.45% | 4.58B | C+ | ||
+17.77% | 4.4B | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- BAYERCROP Stock
- BAYERCROP Stock
- Ratings Bayer CropScience Limited